lyc-30937-ec
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2016 (NCT02818543)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lyc-30937-ec
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02872285 | Phase 2 | Dec 5, 2016 | Lycera Corp. |
| NCT02764229 | Phase 2 | Sep 1, 2016 | Lycera Corp. |
| NCT02762500 | Phase 2 | Jul 1, 2016 | Lycera Corp. |
| NCT02818543 | Phase 1 | Mar 1, 2016 | Lycera Corp. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lycera Corp. | For profit | 4 | 4 | 2 | 2016 |
1 organizations
Page 1 / 1